<p> </p><p>

Chapter ONE

</p><p>1.0 &nbsp; &nbsp; Introduction</p><p>1.1 &nbsp; &nbsp; Anaemia</p><p>1.1.1 Biochemistry</p><p>1.2 &nbsp; &nbsp; Iron therapy</p><p>1.3 &nbsp; &nbsp; Biosynthesis of Heme</p><p>

Chapter TWO

</p><p>2.0 &nbsp; &nbsp; Classification</p><p>2.1 &nbsp; &nbsp; Hyporegenerative</p><p>2.1.1 Aplastic</p><p>2.1.2 Pure red cell aplasia (PRCA)</p><p>2.1.3 related to the myelodysplastic syndrome</p><p>2.1.4 Deficiency</p><p>2.1.5 Bone marrow infiltration and fibrosis</p><p>2.1.6 chronic disease (ACD)</p><p>2.1.7 chronic renal failure</p><p>2.2 &nbsp; &nbsp; Regenerative</p><p>2.2.1 Immune haemolytic</p><p>2.2.2 Sickle cell</p><p>2.2.3 due to enzymopathies and red cell membrane defects</p><p>2.2.4 Haemorrhagic</p><p>

Chapter THREE

</p><p>3.0 &nbsp; &nbsp; Selected</p><p>3.1 &nbsp; &nbsp; Pure red cell aplasia</p><p>3.2 &nbsp; &nbsp; B12 deficiency</p><p>3.3 &nbsp; &nbsp; Immune haemolytic</p><p>3.3.1 Classification</p><p>3.3.2 Pathophysiology of immune haemolytic</p><p>3.3.3 Diagnosis of haemolytic</p><p>3.4 &nbsp; &nbsp; Non-immune haemolytic</p><p>3.4.1 Paroxysmal nocturnal haemoglobinuria (PNH)</p><p>3.4.2 Microangiopathic disorders</p><p>3.4.3 Haemolysis secondary to toxic agents and other causes</p><p>

Chapter FOUR

</p><p>4.0 &nbsp; &nbsp; Conclusion</p><p>References</p> <br><p></p>